Letter by Antignac et al Regarding Article “Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with great interest the article by Wirtz et al,1 which presents an overview on access to cardiovascular medications in low- and middle-income countries. It is noteworthy that, among the 5 health system dimensions of access described, the first 4 have been well researched through large multination studies. Low availability of cardiovascular disease medicines has been well reported; a fairly recent meta-analysis of surveys from 36 countries assessed access to different classes of cardiovascular medicines.1 Several peer-reviewed publications have also reported on the affordability of cardiovascular …